DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slid 1.47% to $8.73 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.28% to 23,501.24 and the Dow Jones Industrial Average falling 0.58% to 49,098.71.
The stock's fall snapped a four-day winning streak.
Corbus Pharmaceuticals Holdings Inc. closed 57.54% below its 52-week high of $20.56, which the company achieved on October 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 1.11% to $8.01, Fortress Biotech Inc. (FBIO) fell 2.30% to $3.40, and Viking Therapeutics Inc. (VKTX) fell 5.49% to $32.22.
Trading volume (100,206) remained 242,257 below its 50-day average volume of 342,463.
Data source: Dow Jones Market Data, FactSet. Data compiled January 23, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 23, 2026 17:21 ET (22:21 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments